Solid Tumours

Related by string. * -SOLID . SOLID . SOLiD . SOLIS . solid . Solis . soli : Metal Gear Solid . Solid Waste Authority . Solid Waste Management . Rogelio V. Solis . solid rocket boosters . Patti Solis Doyle . replaced Solis Doyle / TUMOUR : Tumour Necrosis Factor . Tumour VDA . Tumour Vascular Disrupting Agent . Brain Tumour Foundation . Tumours . Brain Tumour UK . Brain Tumour Research * *

Related by context. Frequent words. (Click for all words.) 72 Solid Tumors 71 Response Evaluation Criteria 66 RECIST criteria 64 RECIST 62 breast carcinoma 62 Thrombolysis 61 Natalizumab 60 Ischemic 60 chemoradiotherapy 60 peripheral blood mononuclear 60 neoadjuvant chemotherapy 60 Chronic Lymphocytic Leukemia 60 leukemia CLL 59 Rheumatoid Arthritis RA 59 immunohistochemical 59 colorectal carcinoma 58 HSCT 58 pharmacodynamic effects 58 multiple myeloma MM 58 malignant pleural mesothelioma 58 Chronic Heart Failure 58 metastatic renal cell carcinoma 58 PsA 58 cytogenetic response 58 epithelial ovarian cancer 58 Radiographic 58 histopathologic 58 HER2 positive metastatic breast 58 juvenile idiopathic arthritis 58 gastrointestinal stromal tumors GIST 58 SYNTAX 57 Myocardial 57 Pathologic 57 PCa 57 thyroid nodules 57 Benign Prostatic Hyperplasia 57 relapsed multiple myeloma 57 multivariate analyzes 57 Lenalidomide 57 neoadjuvant 57 carcinoid 57 Metastatic Melanoma 57 Pharmacokinetic 57 neoadjuvant therapy 57 composite endpoint 57 Secondary endpoints include 57 lung metastases 57 Secondary endpoints 57 prospectively defined 57 Atopic Dermatitis 57 Epratuzumab 57 decitabine 56 SHPT 56 relapsing multiple sclerosis 56 mRCC 56 liver transplant recipients 56 resectable 56 complete cytogenetic 56 evaluable 56 Trastuzumab 56 intravesical 56 tumor lysis syndrome 56 microalbuminuria 56 autologous bone marrow 56 carcinoid tumors 56 GHRH 56 Pulmonary Arterial Hypertension 56 ACR# response 56 estimated glomerular filtration 56 superficial bladder cancer 56 efficacy endpoint 56 Secondary endpoints included 56 pharmacokinetics PK 56 Main Outcome Measures 56 evaluable patients 56 Dasatinib 55 plus dexamethasone 55 mg kg dose 55 #m Tc 55 MetS 55 COPAXONE R 55 K RAS 55 MR spectroscopy 55 T2DM 55 Ankylosing Spondylitis 55 serum concentrations 55 #mg/day [001] 55 C Reactive Protein 55 EORTC 55 Glioma 55 Myocardial Infarction 55 PRECiSE 55 Metastatic Colorectal Cancer 55 Systemic Lupus Erythematosus 55 biochemical recurrence 55 androgen independent 55 Amrubicin 55 chlorambucil 55 Metastatic 55 ischemic cardiomyopathy 55 glioblastoma multiforme GBM

Back to home page